Cure My Disease

Don't miss your cure!

Home News Browse About
Log in / Sign up
← Back to home

Intergroupe Francophone Du Myelome

Clinical trials sponsored by Intergroupe Francophone Du Myelome, explained in plain language.

Trials to join now! 1 Not yet finished but already full! 2
Sort by
  • New drug teclistamab tested in patients with Hard-to-Treat myeloma

    Disease control Ongoing

    This study is tracking 200 adults with multiple myeloma whose cancer has returned or stopped responding to treatment. They are receiving teclistamab, a drug that helps the immune system find and destroy myeloma cells. Researchers are measuring how many patients respond to the dru…

    Sponsor: Intergroupe Francophone du Myelome • Aim: Disease control

    Last updated Jun 27, 2026 12:06 UTC

  • Pee break: spot urine test could end 24-Hour jug hassle for myeloma patients

    Diagnosis Ongoing

    This study tests whether a single urine sample (spot urine) can detect myeloma proteins as accurately as the standard 24-hour urine collection. Researchers will compare results from 180 multiple myeloma patients starting a new treatment. If the spot test works well, it could make…

    Sponsor: Intergroupe Francophone du Myelome • Aim: Diagnosis

    Last updated Jun 27, 2026 12:07 UTC

Cure My Disease

Helping patients find clinical trials that match their disease.

Why was Cure my disease built?

Explore

Home News Browse About Terms of use Contact us

This is a site from Cyber and Space